Cabergoline versus levodopa monotherapy

被引:2
|
作者
Wheatley, K [1 ]
Clarke, CE
Ives, N
机构
[1] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England
[2] City Hosp, Birmingham, W Midlands, England
关键词
D O I
10.1002/mds.20032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:733 / 734
页数:2
相关论文
共 50 条
  • [1] Cabergoline versus levodopa monotherapy:: A decision analysis
    Smala, AM
    Spottke, EA
    Machat, O
    Siebert, U
    Meyer, D
    Köhne-Volland, R
    Reuther, M
    DuChane, J
    Oertel, WH
    Berger, KB
    Dodel, RC
    MOVEMENT DISORDERS, 2003, 18 (08) : 898 - 905
  • [2] Re: Cabergoline versus levodopa monotherapy: A decision analysis
    Marras, C
    MOVEMENT DISORDERS, 2004, 19 (06) : 736 - 736
  • [3] Reply: Cabergoline versus levodopa therapy
    Smala, AM
    Siebert, U
    Oertel, WH
    Dodel, R
    MOVEMENT DISORDERS, 2004, 19 (06) : 734 - 736
  • [4] First Report for Electrochemical Determination of Levodopa and Cabergoline: Application for Determination of Levodopa and Cabergoline in Human Serum, Urine and Pharmaceutical Formulations
    Tajik, Somayeh
    Taher, Mohammad Ali
    Beitollahi, Hadi
    ELECTROANALYSIS, 2014, 26 (04) : 796 - 806
  • [5] Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson's disease: a systematic review
    Jiang, De-Qi
    Wang, Hua-Kun
    Wang, Yan
    Li, Ming-Xing
    Jiang, Li-Lin
    Wang, Yong
    NEUROLOGICAL SCIENCES, 2020, 41 (01) : 101 - 109
  • [6] Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson’s disease: a systematic review
    De-Qi Jiang
    Hua-Kun Wang
    Yan Wang
    Ming-Xing Li
    Li-Lin Jiang
    Yong Wang
    Neurological Sciences, 2020, 41 : 101 - 109
  • [7] Subclinical doses of cabergoline enhance the potency of levodopa
    Kondo, T
    Nakanishi, I
    Miwa, H
    MOVEMENT DISORDERS, 2004, 19 : S250 - S251
  • [10] Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson’s disease: a meta-analysis
    De-Qi Jiang
    Ming-Xing Li
    Li-Lin Jiang
    Xiao-Bai Chen
    Xing-Wen Zhou
    Aging Clinical and Experimental Research, 2020, 32 : 769 - 779